Valerie Ann Perez

Valerie Ann Perez

Auto-generated profile, based on publicly available information

Valerie Ann Perez

The University of Texas Southwestern Medical Center

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 June 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
DCDailu Chen
Dailu Chen
KDKenneth W. Drombosky
Kenneth W. Drombosky
ZHZhiqiang Hou
Zhiqiang Hou
LSLevent Sari
Levent Sari
OKOmar M. Kashmer
Omar M. Kashmer
LJLukasz A. Joachimiak
Lukasz A. Joachimiak
Tauopathies are neurodegenerative diseases characterized by intracellular amyloid deposits of tau protein. Missense mutations in the tau gene (MAPT) correlate with aggregation propensity and cause dominantly inherited tauopathies, but their biophysical mechanism driving amyloid formation is poorly understood. Many disease-associated mutations localize within tau’s repeat domain at inter-repeat interfaces proximal to amyloidogenic sequences, such as 306VQIVYK311. We use cross-linking mass spectrometry, recombinant protein and synthetic peptide systems, in silico modeling, and cell models to conclude that the aggregation-prone 306VQIVYK311 motif forms metastable compact structures with its upstream sequence that modulates aggregation propensity. We report that disease-associated mutations, isomerization of a critical proline, or alternative splicing are all sufficient to destabilize this local structure and trigger spontaneous aggregation. These findings provide a biophysical framework to explain the basis of early conformational changes that may underlie genetic and sporadic tau pathogenesis.

9 September 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
ZHZhiqiang Hou
Zhiqiang Hou
PWPawel M. Wydorski
Pawel M. Wydorski
VPValerie A. Perez
Valerie A. Perez
AMAydé Mendoza-Oliva
Aydé Mendoza-Oliva
BRBryan D. Ryder
Bryan D. Ryder
LJLukasz A. Joachimiak
Lukasz A. Joachimiak
Molecular chaperones, including Hsp70/J-domain protein (JDP) families, play central roles in binding substrates to prevent their aggregation. How JDPs select different conformations of substrates remains poorly understood. Here, we report an interaction between the JDP DnaJC7 and tau that efficiently suppresses tau aggregation in vitro and in cells. DnaJC7 binds preferentially to natively folded wild-type tau, but disease-associated mutants in tau reduce chaperone binding affinity. We identify that DnaJC7 uses a single TPR domain to recognize a β-turn structural element in tau that contains the 275VQIINK280 amyloid motif. Wild-type tau, but not mutant, β-turn structural elements can block full-length tau binding to DnaJC7. These data suggest DnaJC7 preferentially binds and stabilizes natively folded conformations of tau to prevent tau conversion into amyloids. Our work identifies a novel mechanism of tau aggregation regulation that can be exploited as both a diagnostic and a therapeutic intervention.

1 August 2017 in Biomaterials
Verified
Journal Article
Closed access
JCJos L. Campbell
Jos L. Campbell
ESElliott D. SoRelle
Elliott D. SoRelle
OIOhad Ilovich
Ohad Ilovich
OLOrly Liba
Orly Liba
MJMichelle L. James
Michelle L. James
CZCristina Zavaleta
Cristina Zavaleta

30 June 2023 in eLife
Verified
Journal Article
Open access
VPValerie Ann Perez
Valerie Ann Perez
DSDavid W Sanders
David W Sanders
AMAyde Mendoza-Oliva
Ayde Mendoza-Oliva
BSBarbara Stopschinski
Barbara Stopschinski
VMVishruth Mullapudi
Vishruth Mullapudi
MDMarc I Diamond
Marc I Diamond
Neurodegenerative tauopathies are caused by accumulation of toxic tau protein assemblies. This appears to involve template-based seeding events, whereby tau monomer changes conformation and is recruited to a growing aggregate. Several large families of chaperone proteins, including Hsp70s and J domain proteins (JDPs), cooperate to regulate the folding of intracellular proteins such as tau, but the factors that coordinate this activity are not well known. The JDP DnaJC7 binds tau and reduces its intracellular aggregation. However, it is unknown whether this is specific to DnaJC7 or if other JDPs might be similarly involved. We used proteomics within a cell model to determine that DnaJC7 co-purified with insoluble tau and colocalized with intracellular aggregates. We individually knocked out every possible JDP and tested the effect on intracellular aggregation and seeding. DnaJC7 knockout decreased aggregate clearance and increased intracellular tau seeding. This depended on the ability of the J domain (JD) of DnaJC7 to stimulate Hsp70 ATPase activity, as JD mutations that block this interaction abrogated the protective activity. Disease-associated mutations in the JD and substrate binding site of DnaJC7 also abolished its protective activity. DnaJC7 thus specifically regulates tau aggregation in cooperation with Hsp70.

24 January 2025 in Science Advances
Verified
Journal Article
Open access
JVJaime Vaquer-Alicea
Jaime Vaquer-Alicea
VMVictor A. Manon
Victor A. Manon
VBVaibhav Bommareddy
Vaibhav Bommareddy
PKPeter Kunach
Peter Kunach
AGAnkit Gupta
Ankit Gupta
MDMarc I. Diamond
Marc I. Diamond
Distinct tau amyloid assemblies underlie diverse tauopathies but defy rapid classification. Cell and animal experiments indicate tau functions as a prion, as different strains propagated in cells cause unique, transmissible neuropathology after inoculation. Strain amplification requires compatibility of the monomer and amyloid template. We used cryo–electron microscopy to study one cell-based yellow fluorescent protein (YFP)–tagged strain, resolving its amyloid nature. We then used sequential alanine (Ala) substitution (scan) within tau repeat domain (RD) to measure incorporation to preexisting tau RD-YFP aggregates. This robustly discriminated strains, defining sequences critical for monomer incorporation. We then created 3R/4R or 4R wild-type RD (amino acids 246 to 408) biosensors. Ala scan of recombinant tau seeds with the Alzheimer’s disease (AD) fold matched that of AD homogenate. We scanned 22 brain lysates comprising four tauopathies. This clustered cases by neuropathological syndrome, revealed the role of amino acids in protofilament folds, and allowed strain discrimination based on amino acid requirements for prion replication.

17 November 2017 in IEEE Transactions on Medical Imaging
Verified
Journal Article
Closed access
DHDongwoon Hyun
Dongwoon Hyun
LALotfi Abou-Elkacem
Lotfi Abou-Elkacem
VPValerie A. Perez
Valerie A. Perez
SCSayan Mullick Chowdhury
Sayan Mullick Chowdhury
JWJuergen K. Willmann
Juergen K. Willmann
JDJeremy Dahl
Jeremy Dahl
Ultrasound molecular imaging (USMI) is accomplished by detecting microbubble (MB) contrast agents that have bound to specific biomarkers, and can be used for a variety of imaging applications, such as the early detection of cancer. USMI has been widely utilized in preclinical imaging in mice; however, USMI in humans can be challenging because of the low concentration of bound MBs and the signal degradation caused by the presence of heterogenous soft tissue between the transducer and the lesion. Short-lag spatial coherence (SLSC) beamforming has been proposed as a robust technique that is less affected by poor signal quality than standard delay-and-sum (DAS) beamforming. In this paper, USMI performance was assessed using contrast-enhanced ultrasound imaging combined with DAS (conventional CEUS) and with SLSC (SLSC-CEUS). Each method was characterized by flow channel phantom experiments. In a USMI-mimicking phantom, SLSC-CEUS was found to be more robust to high levels of additive thermal noise than DAS, with a 6dB SNR improvement when the thermal noise level was +6dB or higher. However, SLSC-CEUS was also found to be insensitive to increases in MB concentration, making it a poor choice for perfusion imaging. USMI performance was also measured in vivo using VEGFR2-targeted MBs in mice with subcutaneous human hepatocellular carcinoma tumors, with clinical imaging conditions mimicked using a porcine tissue layer between the tumor and the transducer. SLSC-CEUS improved the SNR in each of ten tumors by an average of 41%, corresponding to 3.0dB SNR. These results indicate that the SLSC beamformer is well-suited for USMI applications because of its high sensitivity and robust properties under challenging imaging conditions.